User menu

Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement

Bibliographic reference Perros, P. ; Hegedüs, L. ; Bartalena, L. ; Marcocci, C. ; Kahaly, G. J. ; et. al. Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement. In: Orphanet Journal of Rare Diseases, Vol. 12, p. 72 (2017)
Permanent URL http://hdl.handle.net/2078.1/189885
  1. http://apps.who.int/classifications/icd10/browse/2010/en . Accessed 7 Jan 2017.
  2. Smith Terry J., Hegedüs Laszlo, Graves’ Disease, 10.1056/nejmra1510030
  3. Ponto Katharina A., Merkesdal Sonja, Hommel Gerhard, Pitz Susanne, Pfeiffer Norbert, Kahaly George J., Public Health Relevance of Graves' Orbitopathy, 10.1210/jc.2012-3119
  4. Brandt Frans, Thvilum Marianne, Almind Dorthe, Christensen Kaare, Green Anders, Hegedüs Laszlo, Brix Thomas Heiberg, Morbidity before and after the Diagnosis of Hyperthyroidism: A Nationwide Register-Based Study, 10.1371/journal.pone.0066711
  5. McKeag D., Lane C., Lazarus J. H, Baldeschi L., Boboridis K., Dickinson A J., Hullo A I., Kahaly G., Krassas G., Marcocci C., Marino M., Mourits M. P, Nardi M., Neoh C., Orgiazzi J., Perros P., Pinchera A., Pitz S., Prummel M. F, Sartini M. S, Wiersinga W. M, Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey, 10.1136/bjo.2006.094607
  6. Wiersinga WM. Thyroid autoimmunity. Endocr Dev. 2014;26:139–57.
  7. Bartalena Luigi, Fatourechi Vahab, Extrathyroidal manifestations of Graves’ disease: a 2014 update, 10.1007/s40618-014-0097-2
  8. Perros P., Neoh C., Dickinson J., Thyroid eye disease, 10.1136/bmj.b560
  9. Melcescu Eugen, Horton William B., Kim Daniel, Vijayakumar Vani, Corbett James J., Crowder Kimberly W., Pitman Karen T., Uwaifo Gabriel I., Koch Christian A., Graves Orbitopathy: Update on Diagnosis and Therapy, 10.1097/smj.0000000000000038
  10. Bartalena Luigi, Graves' Orbitopathy: Imperfect Treatments for a Rare Disease, 10.1159/000356042
  11. Tanda M. L., Piantanida E., Liparulo L., Veronesi G., Lai A., Sassi L., Pariani N., Gallo D., Azzolini C., Ferrario M., Bartalena L., Prevalence and Natural History of Graves' Orbitopathy in a Large Series of Patients With Newly Diagnosed Graves' Hyperthyroidism Seen at a Single Center, 10.1210/jc.2012-3873
  12. Wiersinga Wilmar M., Combined Thyroid–Eye Clinics in the Management of Graves’ Ophthalmopathy, Graves' Disease (2015) ISBN:9781493925339 p.187-194, 10.1007/978-1-4939-2534-6_14
  13. Polizzi A, Balsamo A, Bal MO, Taruscio D. Rare diseases research and practice. Endocr Dev. 2014;27:234–56.
  14. Perros Petros, Dayan Colin M., Dickinson A. Jane, Ezra Daniel G., Hickey Janis L., Hintschisch Christoph, Kahaly George, Lazarus John H., Ludgate Marian, Bartès Beate, MacEwen Caroline J., Mitchell Anna L., Morris Dan, O'Connor Nicole, Pearce Simon H., Rose Geoffrey E., Salvi Mario, Wiersinga Wilmar M., Williamson Alyson, , Future Research in Graves' Orbitopathy: From Priority Setting to Trial Design Through Patient and Public Involvement, 10.1089/thy.2015.0222
  15. PERROS PETROS, KENDALL-TAYLOR PAT, Natural History of Thyroid Eye Disease, 10.1089/thy.1998.8.423
  16. Perros Petros, Žarković Miloš, Azzolini Claudio, Ayvaz Göksun, Baldeschi Lelio, Bartalena Luigi, Boschi Antonella, Bournaud Claire, Brix Thomas Heiberg, Covelli Danila, Ćirić Slavica, Daumerie Chantal, Eckstein Anja, Fichter Nicole, Führer Dagmar, Hegedüs Laszlo, Kahaly George J, Konuk Onur, Lareida Jürg, Lazarus John, Leo Marenza, Mathiopoulou Lemonia, Menconi Francesca, Morris Daniel, Okosieme Onyebuchi, Orgiazzi Jaques, Pitz Susanne, Salvi Mario, Vardanian-Vartin Cristina, Wiersinga Wilmar, Bernard Martine, Clarke Lucy, Currò Nicola, Dayan Colin, Dickinson Jane, Knežević Miroslav, Lane Carol, Marcocci Claudio, Marinò Michele, Möller Lars, Nardi Marco, Neoh Christopher, Pearce Simon, von Arx George, Törüner Fosun Baloş, PREGO (presentation of Graves’ orbitopathy) study: changes in referral patterns to European Group On Graves’ Orbitopathy (EUGOGO) centres over the period from 2000 to 2012, 10.1136/bjophthalmol-2015-306733
  17. Weetman A. P., Wiersinga W. M., Current management of thyroid-associated ophthalmopathy in Europe. Results of an international survey, 10.1046/j.1365-2265.1998.00487.x
  18. Abraham-Nordling M., Bystrom K., Torring O., Lantz M., Berg G., Calissendorff J., Nystrom H. F., Jansson S., Jorneskog G., Karlsson F. A., Nystrom E., Ohrling H., Orn T., Hallengren B., Wallin G., Incidence of hyperthyroidism in Sweden, 10.1530/eje-11-0548
  19. Zaletel Katja, Gaberšček Simona, Pirnat Edvard, Krhin Blaž, Hojker Sergej, Ten-year follow-up of thyroid epidemiology in Slovenia after increase in salt iodization, 10.3325/cmj.2011.52.615
  20. Laurberg Peter, Berman Dalia C., Bülow Pedersen Inge, Andersen Stig, Carlé Allan, Incidence and Clinical Presentation of Moderate to Severe Graves' Orbitopathy in a Danish Population before and after Iodine Fortification of Salt, 10.1210/jc.2012-1275
  21. Keiding Niels, Age-Specific Incidence and Prevalence: A Statistical Perspective, 10.2307/2983150
  22. Murray CJ, Lopez AD. Quantifying disability: data, methods and results. Bull World Health Organ. 1994;72:481–94.
  23. Kruijshaar ME, Barendregt JJ, Hoeymans N. The use of models in the estimation of disease epidemiology. Bull World Health Organ. 2002;80:622–8.
  24. http://www.who.int/healthinfo/global_burden_disease/tools_software/en/ . Accessed 7 Jan 2017.
  25. Brandt Frans, Almind Dorthe, Christensen Kaare, Green Anders, Brix Thomas Heiberg, Hegedüs Laszlo, Excess Mortality in Hyperthyroidism: The Influence of Preexisting Comorbidity and Genetic Confounding: A Danish Nationwide Register-Based Cohort Study of Twins and Singletons, 10.1210/jc.2012-2268
  26. Vanderpump M. P. J., Tunbrldge W. M. G., French J. M., Appleton D., Bates D., Clark F., Evans J. Grimley, Hasan D. M., Rodgers H., Tunbridge F., Young E. T., The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey, 10.1111/j.1365-2265.1995.tb01894.x
  27. BERGLUND J., ERICSSON U.-B., HALLENGREN B., Increased incidence of thyrotoxicosis in Malmo during the years 1988-1990 as compared to the years 1970-1974, 10.1046/j.1365-2796.1996.415757000.x
  28. Flynn R. W. V., MacDonald T. M., Morris A. D., Jung R. T., Leese G. P., The Thyroid Epidemiology, Audit, and Research Study: Thyroid Dysfunction in the General Population, 10.1210/jc.2003-032089
  29. Termote K, Decallonne B, Mombaerts I. The influence of prior hyperthyroidism on euthyroid Graves’ Ophthalmopathy. J Ophthalmol. 2014;22:426898.
  30. Eckstein A K, Losch C, Glowacka D, Schott M, Mann K, Esser J, Morgenthaler N G, Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy, 10.1136/bjo.2007.137265
  31. Khoo Daphne H., Eng Peter H., Ho S.C., Tai E.S., Morgenthaler Nils G., Seah L.L., Fong K.S., Chee S.P., Choo C.T., Aw S.E., Graves' Ophthalmopathy in the Absence of Elevated Free Thyroxine and Triiodothyronine Levels: Prevalence, Natural History, and Thyrotropin Receptor Antibody Levels, 10.1089/thy.2000.10.1093
  32. Li Y., Kim J., Diana T., Klasen R., Olivo P. D., Kahaly G. J., A novel bioassay for anti-thyrotrophin receptor autoantibodies detects both thyroid-blocking and stimulating activity : Novel TSHR blocking antibody bioassay, 10.1111/cei.12129
  33. Ponto Katharina A., Binder Harald, Diana Tanja, Matheis Nina, Otto Anna F., Pitz Susanne, Pfeiffer Norbert, Kahaly George J., Prevalence, Phenotype, and Psychosocial Well-Being in Euthyroid/Hypothyroid Thyroid-Associated Orbitopathy, 10.1089/thy.2015.0031
  34. Soroudi A. Ebbie, Goldberg Robert A., McCann John D., Prevalence of Asymmetric Exophthalmos in Graves Orbitopathy : , 10.1097/01.iop.0000124675.80763.5a
  35. Wiersinga Wilmar M., Bleumink Manon, Saeed Peerooz, Baldeschi Lelio, Prummel Mark F., Is Sleeping Position Related to Asymmetry in Bilateral Graves' Ophthalmopathy?, 10.1089/thy.2007.0302
  36. Bartley GB. The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota. Trans Am Ophthalmol Soc. 1994;92:477–588.
  37. Prummel M., Bakker A, Wiersinga W., Baldeschi L, Mourits M., Kendall-Taylor P, Perros P, Neoh C, Dickinson A., Lazarus J., Lane C., Heufelder A., Kahaly G., Pitz S, Orgiazzi J, Hullo A, Pinchera A, Marcocci C, Sartini M., Rocchi R, Nardi M, Krassas G., Halkias A, Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience, 10.1530/eje.0.1480491
  38. Daumerie Ch., Duprez Th., Boschi A., Long-term multidisciplinary follow-up of unilateral thyroid-associated orbitopathy, 10.1016/j.ejim.2008.01.013
  39. Bartalena L., Chiovato L., Graves’-like orbitopathy: do not forget IgG4-related disease, 10.1007/s40618-014-0171-9
  40. Tiegs-Heiden C. A., Eckel L. J., Hunt C. H., Diehn F. E., Schwartz K. M., Kallmes D. F., Salomao D. R., Witzig T. E., Garrity J. A., Immunoglobulin G4-Related Disease of the Orbit: Imaging Features in 27 Patients, 10.3174/ajnr.a3865
  41. Bartley George B., Fatourechi Vahab, Kadrmas Eddie F., Jacobsen Steven J., Ilstrup Duane M., Garrity James A., Gorman Colum A., Long-term Follow-up of Graves Ophthalmopathy in an Incidence Cohort, 10.1016/s0161-6420(96)30579-4
  42. Terwee C, Wakelkamp I, Tan S, Dekker F, Prummel M., Wiersinga W, Long-term effects of Graves' ophthalmopathy on health-related quality of life, 10.1530/eje.0.1460751
  43. http://ec.europa.eu/health/files/eudralex/vol-1/reg_2000_141/reg_2000_141_en.pdf . Accessed 7 Jan 2017.
  44. Aymé Ségolène, Bellet Bertrand, Rath Ana, Rare diseases in ICD11: making rare diseases visible in health information systems through appropriate coding, 10.1186/s13023-015-0251-8
  45. http://www.ema.europa.eu/docs/en_GB/document_library/Other/2015/08/WC500191754.pdf . Accessed 7 Jan 2017.